Prof. David D'Cruz, Consultant Rheumatologist

Prof. David D'Cruz

Consultant Rheumatologist

Book online
|

Prof. David D'Cruz MD FRCP

Consultant Rheumatologist

MD FRCP

Prof. David D'Cruz

Consultant Rheumatologist MD FRCP

Book online
|
MD FRCP

Areas of expertise

  • Joint injection
  • Rheumatology
  • Soft tissue injection
  • Antiphospholipid syndrome
  • Connective tissue disease

Recommendations for Prof. D'Cruz

These recommendations are for information purposes only. Doctors providing recommendations do so in good faith and are not responsible for clinical outcomes.

Recommended by:

  • byDr Alexandra Mary Elaine Oliver, GP

    A very good lupus specialist

  • byDr Brian Clapp, Consultant Cardiologist

    I tend to send my patients for rheumatological consultations to Prof. David D'Cruz.

  • byDr Alexandra Mary Elaine Oliver, GP

    A very good lupus specialist

  • byDr Brian Clapp, Consultant Cardiologist

    I tend to send my patients for rheumatological consultations to Prof. David D'Cruz.

  • Address

    • London Bridge Hospital

      27 Tooley Street, London, SE1 2PR

    About Prof. David D'Cruz

    GMC number: 2823508

    Year qualified: 1983

    Place of primary qualification: University of London

    Mr David d'Cruz is a Consultant Rheumatologist based in London. He specialises in systemic lupus erythematosus, the antiphospholipid syndrome, and systemic vasculitis. Mr d'Cruz qualified from St Mary's Hospital Medical School in London and completed his Senior House Officer and Registrar rotations at University College and the Royal London Hospital. He then undertook a Clinical Registrar post and an ARC Clinical Research Fellowship at St Thomas' Hospital, which led to an MD degree. Following this, he was appointed as a Senior Registrar at St Bartholomew's and The Royal London Hospitals and was soon promoted to Senior Lecturer in Rheumatology.

    Mr d'Cruz has published over 100 peer-reviewed papers, 25 editorials and reviews, and has authored 15 book chapters. He is the Editor in Chief of the Journal of Autoimmune Diseases and a Managing Editor of the journal Lupus.

    His areas of expertise include joint injection, rheumatology, soft tissue injection, antiphospholipid syndrome, connective tissue disease, systemic lupus erythematosus (SLE), and vasculitis. Mr d'Cruz has been providing exceptional care to his patients since his appointment and continues to contribute significantly to the field of rheumatology through his clinical and research work.

    Areas of expertise

    • Connective Tissue Disease
    • Lupus
    • General Rheumatology
    • Vasculitis
    • Joint injection
    • Rheumatology
    • Soft tissue injection
    • Antiphospholipid syndrome

    Professional memberships

    Royal College of Physicians
    General Medical Council

    Articles by Prof. David D'Cruz

    Is it me? the impact of patient-physician interactions on lupus patients' psychological well-being, cognition and health-care-seeking behaviour clinical science rheumatology advances in practice

    Respiratory subtype of relapsing polychondritis (rp) frequently presents as difficult asthma: a descriptive study of respiratory involvement in rp with 13 patients from a single uk centre

    The impact of the covid-19 pandemic on the medical care and healthcare-behaviour of patients with lupus and other systemic autoimmune diseases: a mixed methods longitudinal study

    Medically explained symptoms: a mixed methods study of diagnostic, symptom and support experiences of patients with lupus and related systemic autoimmune diseases

    Is it me? the impact of patient-physician interactions on lupus patients' psychological well-being, cognition and health-care-seeking behaviour

    The impact of covid-19 and the uk’s shielding guidance on patients with lupus and related systemic autoimmune rheumatic diseases

    Two subsets of human marginal zone b cells resolved by global analysis of lymphoid tissues and blood

    ‘but you don’t look sick’: a qualitative analysis of the lupus uk online forum

    Human marginal zone b cell development from early t2 progenitors

    An update on the management of antiphospholipid syndrome